pharma
Bayer secures one-two treatment for liver cancer after EU approval
August 7, 2017Sales and Marketing Bayer, biotech, drugs, pharma, pharmaceutical
Bayer has announced that it has received European Commission approval for its treatment of hepatocellular carcinoma, a type of liver …
Stomach acid drugs do not increase Alzheimer’s risk, study confirms
August 7, 2017Research and Development, Sales and Marketing Alzheimer's, dementia, drugs, healthcare, lansoprazole, life sciences, medicine, omeprazole, pharma, pharmaceuticals, proton pump inhibitors
A new study from the University of Eastern Finland has indicated that the use of proton pump inhibitors such as …
HIV-preventing drug to be trialed across England
August 7, 2017Medical Communications, Sales and Marketing NHS, NHS England, PrEP, Truvada, biotech, drugs, pharma, pharmaceutical
NHS England has announced that it will finally make the HIV-preventing drug, PrEP, available to those at risk with the …
Vernalis cough and cold drug knocked-back by FDA
August 7, 2017Sales and Marketing Vernalis, biotech, drugs, pharma, pharmaceutical, tris pharma
Vernalis has been given a second CRL for a cough and cold treatment by the FDA this year. The therapy, …
FDA fast tracks Valneva’s Lyme disease vaccine
August 7, 2017Research and Development, Sales and Marketing Valneva, biotech, life sciences, lyme disease, medicines, pharma, pharmaceutcial
French firm Valneva has announced that its Lyme disease vaccine, known at this stage only by VLA15, has been fast-tracked …
Jeff Huber, former Google exec, steps down as CEO of GRAIL
August 4, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GRAIL, Jeff Huber, biotech, drugs, google, pharma, pharmaceutical
Jeff Huber, a former Google executive who spent 14 years at the company, has announced that he will step from …
Top Ten most popular articles on Pharmafile.com this week
August 4, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, biotech, drugs, healthcare, life sciences, medicines, pharma, pharmaceuticals, top ten
Another week passes by, and the headlines have seen some shocking stories, such as the news that the UK is …
Bristol-Myers Squibb’s $2.3 billion gamble to boost cancer pipeline
August 4, 2017Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, IFM Therapeutics, biotech, drugs, pharma, pharmaceutical
Bristol-Myers Squibb has agreed a deal to acquire IFM Therapeutics for a potential $2.3 billion. The latter is a biotech …
NICE greenlights Celgene pancreatic cancer drug as first-line combination treatment
August 4, 2017Medical Communications, Sales and Marketing Cancer, Celgene, NICE, Pancreatic cancer, drugs, healthcare, life sciences, medicine, pharma, pharmaceuticals
Celgene is celebrating following NICE’s announcement that it had decided to recommend the use of nab-Paclitaxel, when used in combination …
Chan Zuckerberg Initiative injects $10 million into US big data healthcare project
August 4, 2017Medical Communications, Research and Development Big Data, Chan Zuckerberg initiative, biotech, drugs, healthcare, life sciences, medicine, pharma, pharmaceutical
Facebook CEO Mark Zuckerberg and philanthropist Priscilla Chan have continued their quest to improve worldwide healthcare with the latest donation …
Diabetes drug holds promise to slow Parkinson’s progression
August 4, 2017Medical Communications, Research and Development Parkinson's disease, biotech, diabetes, drugs, pharma, pharmaceutical
There are currently no treatments that are able to slow the development of Parkinson’s disease. This unmet medical need will …
Teva releases financials, shares fall off cliff, plans to axe 7000 jobs
August 3, 2017Medical Communications Teva, biotech, drugs, pharma, pharmaceutical
Teva has released its second quarter financials and they do not make for great reading if you’re an investor. The …
FDA turns down Janssen’s sirukumab for rheumatoid arthritis
August 3, 2017Sales and Marketing FDA, Janssen, drugs, life sciences, medicine, pharma, pharmaceuticals, rheumatoid arthritis, sirukumab
Janssen has announced that it has suffered a knockback to its plans to commercialise sirukumab in the US in the …
Existing arthritis drug could save thousands in blood cancer treatment
August 3, 2017Research and Development University of Sheffield, arthritis, biotech, blood cancer, drugs, life sciences, medicine, pharma, pharmaceutical
Findings by researchers at the University of Sheffield have indicated that thousands of pounds could be saved in blood cancer …
The common cold cured?
August 3, 2017Research and Development biotech, cold, drugs, pharma, pharmaceutical, rhinovirus
Researchers from Edinburgh Napier University have discovered a crucial step in bringing forward a cure for the common cold. The …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
